Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

475

HTML

4853

Figures (1-4)

317

Tables (1-12)

310

Sum=5955

May 14, 2009 (publication date) through Jan 23, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlights

World J Gastroenterol. May 14, 2009; 15(18): 2190-2203
Published online May 14, 2009. doi: 10.3748/wjg.15.2190

Table 4 Features of the ideal non-invasive method for liver fibrosis

Reliable (high diagnostic accuracy)

Widely available (simple, least expensive)

Providing information on both fibrosis stage and fibrogenesis activity

Validated by large-scale studies

Validated by independent studies (different authors from the proposing study)

Validated in various etiologies of CLDs (HCV, HBV, ALD, NAFLD)

Identifying clinically important fibrosis stages (significant fibrosis and cirrhosis)

CLDs: Chronic liver diseases; ALD: Alcoholic liver disease; NAFLD: Non-alcoholic fatty liver disease.

Citation: Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203
URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2190.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2190